Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction An Analysis from HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)

JACC: Cardiovascular Interventions

Volumn 8, Issue 15, 2015, Pages 1966-1974

  Prasad, Abhiram ^a,b   Gersh, Bernard J ^a   Mehran, Roxana ^c,d   Brodie, Bruce R ^e   Brener, Sorin J ^d,f   Dizon, José M ^g   Lansky, Alexandra J ^h   Witzenbichler, Bernhard ⁱ   Kornowski, Ran ^j   Guagliumi, Giulio ^k   Dudek, Dariusz ^l   Stone, Gregg W ^d,g  

^a MAYO CLINIC   (United States)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e LeBauer Cardiovasc Res Found M   (United States)

^f NEW YORK METHODIST HOSPITAL   (United States)

^g NewYork Presbyterian Hospital   (United States)

^h YALE UNIVERSITY   (United States)

ⁱ Helios Amper Klinikum   (Germany)

^j RABIN MEDICAL CENTER   (Israel)

^k PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^l JAGIELLONIAN UNIVERSITY   (Poland)

more..

Author keywords

ischemia duration; myocardial infarction; PCI; perfusion; STEMI

Indexed keywords

ADULT; AGE; ARTERY DIAMETER; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY BLOOD FLOW; CORONARY REPERFUSION; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL BLUSH GRADE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY DELAY; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; CONTROLLED STUDY; DEVICES; DRUG ELUTING STENT; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; PATHOPHYSIOLOGY; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STENT; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY;

METAL;

AGED; AGED, 80 AND OVER; CORONARY CIRCULATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84952031403     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.08.031     Document Type: Article

References (32)

1. G.W. Stone, A.J. Lansky, S.J. Pocock, and et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
2. A. Prasad, G.W. Stone, E. Aymong, and et al. Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: an analysis from the CADILLAC trial Am Heart J 147 2004 669 675
3. M. Srinivasan, C.S. Rihal, D. Holmes, and A. Prasad Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes Circulation 119 2009 1311 1319
4. M. Francone, C. Bucciarelli-Ducci, I. Carbone, and et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 2145 2153
5. G. Tarantini, L. Cacciavillani, F. Corbetti, and et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast enhanced magnetic resonance J Am Coll Cardiol 46 2005 1229 1235
6. G. De Luca, A.W. van 't Hof, M.J. de Boer, and et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 25 2004 1009 1013
7. M.L. Fokkema, W.G. Wieringa, I.C. Van Der Horst, E. Boersma, F. Zijlstra, and B.J. De Smet Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction Am J Cardiol 108 2011 1536 1541
8. R. Schroder, R. Dissmann, T. Bruggemann, and et al. Extent of early ST-segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
9. R. Schroder, K. Wegscheider, K. Schroder, and et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
10. G.M. Santoro, D. Antoniucci, R. Valenti, and et al. Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction Am J Cardiol 80 1997 685 689
11. J.A. de Lemos, E.M. Antman, C.H. McCabe, and et al. ST-segment resolution and infarct related artery patency and flow after thrombolytic therapy Am J Cardiol 85 2000 299 304
12. C.M. Gibson, C.P. Cannon, S.A. Murphy, and et al. The relationship of the TIMI myocardial perfusion grade to mortality after thrombolytic administration Circulation 101 2000 125 130
13. A.W. van 't Hof, A. Liem, H. Suryapranata, and et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306
14. G.W. Stone, M.A. Peterson, A.J. Lansky, and et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J Am Coll Cardiol 39 2002 591 597
15. J.P. Henriques, F. Zijlstra, A.W. van't Hof, and et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade Circulation 107 2003 2115 2119
16. D.A. Morrow, E.M. Antman, A. Charlesworth, and et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
17. B.R. Brodie, B.J. Gersh, T. Stuckey, and et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI and CADILLAC trials J Am Coll Cardiol 56 2010 407 413
18. P.K. Haager, P. Christott, N. Heussen, W. Lepper, P. Hanrath, and R. Hoffmann Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion J Am Coll Cardiol 41 2003 532 538
19. C.O. Costantini, G.W. Stone, R. Mehran, and et al. Frequency, correlates and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J Am Coll Cardiol 44 2004 305 312
20. P. Sorajja, B.J. Gersh, C. Costantini, and et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur Heart J 26 2005 667 674
21. A. Prasad, G. Stone, D. Holmes, and B. Gersh Reperfusion injury, microvascular dysfunction and cardioprotection: the "dark side" of reperfusion Circulation 120 2009 2105 2112
22. C. Basso, F. Corbetti, C. Silva, and et al. Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance Am J Cardiol 100 2007 1322 1327
23. O. Fröbert, B. Lagerqvist, G.K. Olivecrona, and et al. Thrombus aspiration during ST-segment elevation myocardial infarction N Engl J Med 369 2013 1587 1597
24. S.S. Jolly, J.A. Cairns, S. Yusuf, and et al. Randomized trial of primary PCI with or without routine manual thrombectomy N Engl J Med 372 2015 1389 1398
25. D. Carrick, K.G. Oldroyd, M. McEntegart, and et al. A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI) J Am Coll Cardiol 63 2014 2088 2098
26. H. Kelbæk, C.J. Terkelsen, S. Helqvist, and et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction (DEDICATION) trial J Am Coll Cardiol 51 2008 899 905
27. J. Lønborg, N. Vejlstrup, H. Kelbæk, and et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
28. C. Piot, P. Croisille, P. Staat, and et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
29. G.W. Stone, A. Maehara, B. Witzenbichler, and et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
30. A. Flynn, M. Moscucci, D. Share, and et al. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention Arch Intern Med 170 2010 1842 1849
31. D.S. Menees, E.D. Peterson, Y. Wang, J.P. Curtis, J.C. Messenger, J.S. Rumsfeld, and H.S. Gurm Door-to-balloon time and mortality among patients undergoing primary PCI N Engl J Med 369 2013 901 909
32. C.J. Terkelsen, J.T. Sørensen, M. Maeng, and et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention JAMA 304 2010 763 771